ContributorsPublishersAdvertisers

Daratumumab Combination Therapy Established Standard of Care for Newly Diagnosed Multiple Myeloma

targetedonc.com
 2021-10-04

Cover picture for the articleA recent presentation during the 18th International Myeloma Workshop focused on updated efficacy and safety data for daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone after nearly 5 years of median follow-up in the phase 3 MAIA study. Daratumumab (Darzalex) plus lenalidomide (Revlimid) and dexamethasone provided a significant...

www.targetedonc.com

Comments / 0

Comments / 0